Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

Published:2021-12-21 Issue:23 Volume:326 Page:2395
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Ray Wayne A.¹,Chung Cecilia P.²,Stein C. Michael²³,Smalley Walter¹²,Zimmerman Eli⁴,Dupont William D.¹⁵,Hung Adriana M.²⁶,Daugherty James R.¹,Dickson Alyson²,Murray Katherine T.²³

Affiliation:

1. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

2. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

3. Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

4. Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee

5. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee

6. Veterans Affairs Tennessee Valley Healthcare System, Nashville Campus

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2787319/jama_ray_2021_oi_210130_1640024200.51817.pdf

Reference42 articles.

1. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights.;Kornej;Circ Res,2020

2. Atrial fibrillation.;Zimetbaum;Ann Intern Med,2017

3. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.;January;Circulation,2019

4. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010-2017.;Zhu;Pharmacotherapy,2018

5. Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.;Gong;Can J Cardiol,2013

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period;The American Journal of Emergency Medicine;2024-11

2. Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study;Frontiers in Pharmacology;2024-09-06

3. Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation;Clinical Cardiology;2024-09

4. Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate;BJU International;2024-08-29

5. Ten rules for oral anticoagulants prescription after a stroke;Neurology, Neuropsychiatry, Psychosomatics;2024-08-22